The industry urgently needs to understand that its current approach to policy is almost pre-destined to deliver disappointment and poor outcomes. …
The choice is to be more defensive or continue to suffer bad outcomes
September 19, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Liberty expands into Asia Pacific life sciences insurance with new tailored offering
March 25, 2026 - - Australian Biotech -
Faster FDA pathway approves new higher dose weight loss therapy in just 54 days
March 25, 2026 - - Latest News -
Small changes can still become foundations for the meaningful, but understand how decisions are made
March 25, 2026 - - Latest News -
Australia moves closer to Europe as health and research ties deepen under landmark agreement
March 25, 2026 - - Latest News -
Auditor General proposes possible reviews of new Centre for Disease Control
March 24, 2026 - - Latest News -
Radiopharm reports strong interim results for brain metastases imaging agent
March 24, 2026 - - Australian Biotech -
Cyclopharm expands US footprint with major multi site agreement in leading academic health system
March 24, 2026 - - Australian Biotech